Similar articles

• CNS and pituitary effects of hypothalamic peptides and MSH.

  Kastin AJ, Miller LH, Sandman CA, Schally AV, Plotnikoff NP. Kastin AJ, et al. Essays Neurochem Neuropharmacol. 1977;1:139-76. Essays Neurochem Neuropharmacol. 1977. PMID: 30623 Review.
• Modification of pentobarbital effects by natural and synthetic polypeptides: dissociation of brain and pituitary effects.

  Prange AJ Jr, Breese GR, Jahnke GD, Martin BR, Cooper BT, Cott JM, Wilson IC, Alltop LB, Lipton MA, Bissette G, Nemeroff CG, Loosen PT. Prange AJ Jr, et al. Life Sci. 1975 Jun 15;16(12):1907-13. doi: 10.1016/0024-3205(75)90300-8. Life Sci. 1975. PMID: 239299 No abstract available.
• Commentary: Neuropharmacology of hypothalamic releasing factors.

  Plotnikoff NP, Kastin AJ. Plotnikoff NP, et al. Biochem Pharmacol. 1976 Feb 15;25(4):363-5. doi: 10.1016/0006-2952(76)90332-4. Biochem Pharmacol. 1976. PMID: 7268 No abstract available.
• Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.

  Agarwal RA, Rastogi RB, Singhal RL. Agarwal RA, et al. Res Commun Chem Pathol Pharmacol. 1976 Dec;15(4):743-52. Res Commun Chem Pathol Pharmacol. 1976. PMID: 12549
• CNS effects of peripherally administered brain peptides.

  Kastin AJ, Olson RD, Schally AV, Coy DH. Kastin AJ, et al. Life Sci. 1979 Jul 30;25(5):401-14. doi: 10.1016/0024-3205(79)90572-1. Life Sci. 1979. PMID: 39214 Review. No abstract available.